Page 101 - Amgen News Today

Rosenberg Matthew Hamilton increased its holdings in Amgen Inc. (NASDAQ:AMGN – Free Report) by 4.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 831 shares of the medical research company’s stock after acquiring an additional 37 shares during the period. Rosenberg Matthew […]

Amgen is testing whether its new drug, a potential competitor to Novo Nordisk's hugely popular Ozempic, can be taken once a month or less

Retirement Planning Group LLC bought a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 1,202 shares of the medical research company’s stock, valued at approximately $346,000. Several other institutional investors […]

Sterling Investment Counsel LLC grew its stake in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 17.1% during the 4th quarter, HoldingsChannel reports. The fund owned 1,975 shares of the medical research company’s stock after acquiring an additional 288 shares during the period. Sterling Investment Counsel LLC’s holdings in Amgen were worth $569,000 as […]

Merrion Investment Management Co LLC increased its holdings in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 20.8% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 2,468 shares of the medical research company’s stock after purchasing an additional 425 shares […]

Everhart Financial Group Inc. boosted its stake in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 13.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,828 shares of the medical research company’s stock after acquiring an additional 214 shares […]

Twelve Points Wealth Management LLC lifted its stake in Amgen Inc. (NASDAQ:AMGN – Free Report) by 5.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,628 shares of the medical research company’s stock after purchasing an additional 87 shares during […]

Advisor Resource Council bought a new stake in Amgen Inc. (NASDAQ:AMGN – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 2,955 shares of the medical research company’s stock, valued at approximately $851,000. A number of other […]

McGuire Investment Group LLC cut its stake in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 3.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 14,652 shares of the medical research company’s stock after selling 599 shares during the […]

It's already benefiting from AI tailwinds that are just going to get stronger.